Edition:
United States

Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)

0460.HK on Hong Kong Stock

2.87HKD
26 Sep 2017
Change (% chg)

HK$0.00 (+0.00%)
Prev Close
HK$2.87
Open
HK$2.88
Day's High
HK$2.89
Day's Low
HK$2.85
Volume
9,868,220
Avg. Vol
27,356,146
52-wk High
HK$3.76
52-wk Low
HK$1.64

Chart for

About

Sihuan Pharmaceutical Holding Group Ltd. is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company is mainly engaged in the research and development, manufacture and sales of pharmaceutical products in China. Its products are applicable in cardio-cerebral vascular (CCV) system,... (more)

Overall

Beta: -0.10
Market Cap(Mil.): HK$27,182.01
Shares Outstanding(Mil.): 9,471.08
Dividend: 0.02
Yield (%): 2.20

Financials

  Industry Sector
P/E (TTM): -- 30.47 15.77
EPS (TTM): -- -- --
ROI: -- 14.26 15.19
ROE: -- 15.57 13.80

BRIEF-Sihuan Pharmaceutical says unit to invest in Pharmadax Foshan

* Hainan Sihuan Pharmaceutical, a unit of co, recently entered into agreements with Pharmadax Inc

Sep 03 2017

BRIEF-Sihuan Pharmaceutical updates on patent infringement claim related to product

Aug 22 Sihuan Pharmaceutical Holdings Group Ltd :

Aug 21 2017

BRIEF-Sihuan Pharmaceutical sets up R&D centre in in California

* Sihuan pharmaceutical -set up its United States research and development centre in san francisco bay area in california Source text for Eikon: Further company coverage:

Aug 15 2017

BRIEF-Sihuan Pharmaceutical Holdings announces establishment joint venture

June 12 Sihuan Pharmaceutical Holdings Group Ltd :

Jun 12 2017

BRIEF-Sihuan Pharmaceutical posts FY profit attributable of RMB 1.71 bln

March 29 Sihuan Pharmaceutical Holdings Group Ltd

Mar 28 2017

Earnings vs. Estimates